SANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer
Clinical trial NCT02600390 · COMPLETED
Trial details
- NCT number
- NCT02600390
- Sponsor
- Prolong Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2016-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.